Annual SGA
$17.32 M
-$7.00 M-28.79%
December 31, 2023
Summary
- As of March 9, 2025, VIRX annual SGA is $17.32 million, with the most recent change of -$7.00 million (-28.79%) on December 31, 2023.
- During the last 3 years, VIRX annual SGA has risen by +$11.98 million (+223.93%).
- VIRX annual SGA is now -28.79% below its all-time high of $24.33 million, reached on December 31, 2022.
Performance
VIRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.00 M
-$37.00 K-1.22%
September 30, 2024
Summary
- As of March 9, 2025, VIRX quarterly SGA is $3.00 million, with the most recent change of -$37.00 thousand (-1.22%) on September 30, 2024.
- Over the past year, VIRX quarterly SGA has dropped by -$1.15 million (-27.68%).
- VIRX quarterly SGA is now -72.54% below its all-time high of $10.94 million, reached on September 30, 2022.
Performance
VIRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.12 B
-$43.29 M-4.02%
September 30, 2024
Summary
- As of March 9, 2025, VIRX TTM SGA is -$1.12 billion, with the most recent change of -$43.29 million (-4.02%) on September 30, 2024.
- Over the past year, VIRX TTM SGA has dropped by -$1.14 billion (-6572.89%).
- VIRX TTM SGA is now -2102.42% below its all-time high of -$50.91 million.
Performance
VIRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VIRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.8% | -27.7% | -6572.9% |
| 3 y3 years | +223.9% | -27.7% | -6572.9% |
| 5 y5 years | +223.9% | -27.7% | -6572.9% |
VIRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.8% | +12.2% | -72.5% | at low | -90.3% | at low |
| 5 y | 5-year | -28.8% | +223.9% | -72.5% | +241.8% | -2102.4% | at low |
| alltime | all time | -28.8% | +223.9% | -72.5% | +241.8% | -2102.4% | at low |
Viracta Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.00 M(-1.2%) | $14.12 M(-8.5%) |
| Jun 2024 | - | $3.04 M(-22.4%) | $15.43 M(-7.3%) |
| Mar 2024 | - | $3.92 M(-5.6%) | $16.64 M(-3.9%) |
| Dec 2023 | $17.32 M(-28.8%) | $4.15 M(-3.8%) | $17.32 M(-4.0%) |
| Sep 2023 | - | $4.32 M(+1.5%) | $18.04 M(-26.8%) |
| Jun 2023 | - | $4.25 M(-7.5%) | $24.66 M(+0.3%) |
| Mar 2023 | - | $4.60 M(-5.6%) | $24.59 M(+1.1%) |
| Dec 2022 | $24.33 M | $4.87 M(-55.5%) | $24.33 M(+3.6%) |
| Sep 2022 | - | $10.94 M(+161.6%) | $23.47 M(+44.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $4.18 M(-3.6%) | $16.24 M(+1.9%) |
| Mar 2022 | - | $4.34 M(+8.0%) | $15.93 M(+3.2%) |
| Dec 2021 | $15.44 M(+188.6%) | $4.01 M(+8.2%) | $15.44 M(+10.3%) |
| Sep 2021 | - | $3.71 M(-4.1%) | $13.99 M(+25.3%) |
| Jun 2021 | - | $3.87 M(+0.8%) | $11.17 M(+36.6%) |
| Mar 2021 | - | $3.84 M(+49.4%) | $8.18 M(+52.9%) |
| Dec 2020 | $5.35 M | $2.57 M(+189.9%) | $5.35 M(+92.6%) |
| Sep 2020 | - | $887.00 K(+0.9%) | $2.78 M(+46.9%) |
| Jun 2020 | - | $879.00 K(-13.1%) | $1.89 M(+86.9%) |
| Mar 2020 | - | $1.01 M | $1.01 M |
FAQ
- What is Viracta Therapeutics annual SGA?
- What is the all time high annual SGA for Viracta Therapeutics?
- What is Viracta Therapeutics annual SGA year-on-year change?
- What is Viracta Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly SGA year-on-year change?
- What is Viracta Therapeutics TTM SGA?
- What is the all time high TTM SGA for Viracta Therapeutics?
- What is Viracta Therapeutics TTM SGA year-on-year change?
What is Viracta Therapeutics annual SGA?
The current annual SGA of VIRX is $17.32 M
What is the all time high annual SGA for Viracta Therapeutics?
Viracta Therapeutics all-time high annual SGA is $24.33 M
What is Viracta Therapeutics annual SGA year-on-year change?
Over the past year, VIRX annual SGA has changed by -$7.00 M (-28.79%)
What is Viracta Therapeutics quarterly SGA?
The current quarterly SGA of VIRX is $3.00 M
What is the all time high quarterly SGA for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly SGA is $10.94 M
What is Viracta Therapeutics quarterly SGA year-on-year change?
Over the past year, VIRX quarterly SGA has changed by -$1.15 M (-27.68%)
What is Viracta Therapeutics TTM SGA?
The current TTM SGA of VIRX is -$1.12 B
What is the all time high TTM SGA for Viracta Therapeutics?
Viracta Therapeutics all-time high TTM SGA is -$50.91 M
What is Viracta Therapeutics TTM SGA year-on-year change?
Over the past year, VIRX TTM SGA has changed by -$1.14 B (-6572.89%)